Five Commercialization Mistakes Biotech Companies Make Before Launch (And a Checklist to Avoid Them)
Getting a drug approved is brutal. According to Tufts CSDD, only about 12% of drug candidates that enter clinical trials are ultimately approved, and CSDD's analysis put the full lifecycle cost of bri ...